BOSTON (CBS) – Multiple sclerosis is a devastating disease, but a pharmaceutical based here in Massachusetts is developing a drug that they hope will ease suffering for a lot of MS patients.

Biogen Idec has just announced that this drug is a step closer to being approved. How will the news impact the company’s stock?

Lisa van der Pool of the Boston Business Journal reports: